Oncology

Latest News

Within 5 years, the risk of SCC in particular was heightened among patients with MMP. | Image credit: wavebreak3 - stock.adobe.com
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers

April 21st 2025

The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.

AI technology | Image: Adobe Stock
Tech Updates: McKesson Launches Precision Oncology Consortium; Financing for RISA Labs PA Platform

April 17th 2025

IVBM Atlanta | Image credit: AJMC
Making Novel Cancer Therapies Available Requires Choices Because Resources Are Limited

April 14th 2025

Businessman shows medical network wooden block for health, medicine, insurance, healthcare, care, concept. Medical technology services to solve public - ภัทรชัย รัตนชัยวงค์ - stock.adobe.com.jpeg
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer

April 9th 2025

AJMC
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

April 4th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Site Logo
October 19th 2015

Ensuring Education for Stakeholders of Personalized Medicine

Surabhi Dangi-Garimella, PhD
A panel discussion at the PMC/BIO Solutions Summit in Washington, DC, saw an exchange on widespread and appropriate education of personalized medicine among payers, providers, patients, and families.
Dr Veena Shankaran Examines Financial Burdens Facing Cancer Patients
October 18th 2015

Dr Veena Shankaran Examines Financial Burdens Facing Cancer Patients

There are a number of financial hardships patients with cancer can face, even if they are insured, such as loss of employment, depletion of retirement accounts, and bankruptcy, said Veena Shankaran, MD, MS.
This Week in Managed Care: October 17, 2015
October 17th 2015

This Week in Managed Care: October 17, 2015

Top managed care stories this week include comparing US healthcare spending and outcomes to other wealthy nations, identifying how many Americans are affected by Medicaid expansion coverage gaps, and a look at adolescents and young patients with cancer.
Site Logo
October 16th 2015

NCCN Unveils Value Tool for CML and MM

AJMC Staff
NCCN Evidence Blocks add affordability to Guidelines recommendations on safety, efficacy, quality, and consistency of regimens.
Site Logo
October 16th 2015

Antibiotic Resistance Can Negate the Value of Surgery and Cancer Immunotherapy

Surabhi Dangi-Garimella, PhD
The results of a study published in The Lancet Infectious Diseases necessitate a wake-up call for stakeholders to develop a new approach that can overcome the rapidly-growing threat of antibiotic resistance.
Site Logo
October 16th 2015

Rapid Innovation in Medical Diagnostics a Major Challenge for Payers

Surabhi Dangi-Garimella, PhD
Not just providers of care, but payers as well have been having a hard time embracing the rapidly-evolving and dynamic field of personalized medicine, according to panel members at the recently held PMC/BIO Solutions Summit.
Site Logo
October 15th 2015

Health Plan Recommends More Interventions for Tangible Results With Choosing Wisely

Surabhi Dangi-Garimella, PhD
The analysis by Anthem Inc, has identified a need for more widespread implementation of these interventions aimed at reducing healthcare utilization.
Site Logo
October 15th 2015

Study Confirms: Calcium and Vitamin D Cannot Prevent Colon Cancer

Surabhi Dangi-Garimella, PhD
The study, published in the New England Journal of Medicine failed to confirm epidemiologic and preclinical data that vitamin D and calcium can reduce the risk of colorectal neoplasia.
Mary Lou Smith on Ensuring Patients Feel Cared For
October 15th 2015

Mary Lou Smith on Ensuring Patients Feel Cared For

One way to make all patients with cancer, regardless of socioeconomic status, feel like they're on the same level when receiving treatment is to ensure they know they're being taken care of, said Mary Lou Smith, MBA, co-founder of the Research Advocacy Network.
Site Logo
October 15th 2015

Organization That Addresses "Financial Toxicity" in Young Cancer Survivors Featured in Evidence-Based Oncology

The Samfund, the first and largest group created to help young adults address the costs of cancer, is featured in the current issue of Evidence-Based Oncology, a publication of The American Journal of Managed Care. Samfund officers Samantha Watson, MBA, and Michelle S. Landwehr, MPH, address the challenges of "financial toxicity" for young adult survivors.
Site Logo
October 15th 2015

Patient Advocacy Meets Payer in the World of Personalized Medicine

Surabhi Dangi-Garimella, PhD
A panel discussion during the 2nd PMC/BIO Solutions Summit identified barriers and discussed the path forward to improve clinical integration of precision medicine.
Site Logo
October 14th 2015

Financial Toxicity and the Young Adult Cancer Survivor

Samantha Watson, MBA Michelle S. Landwehr, MPH
The financial aftereffects of cancer have a tremendous impact on young adults as they move forward with their lives after treatment.
Site Logo
October 14th 2015

FDA Updates in Oncology

Surabhi Dangi-Garimella, PhD
Updates on FDA approvals and extended indications for oncology drugs.
Site Logo
October 14th 2015

Using a Gene Expression Assay to Predict Response to NAC in Breast Cancer

Surabhi Dangi-Garimella, PhD
Evaluation of Prosigna's risk of relapse score as a predictor of response to multiagent neoadjuvant chemotherapy in HR+/HER2 breast cancer patients.
Site Logo
October 14th 2015

Managed Care Updates in Oncology

Surabhi Dangi-Garimella, PhD Mary Caffrey
An update on recent progress in oncology managed care.
Dr Peter Bach on the Benefit of Bringing Stakeholders Together at PCOC15
October 14th 2015

Dr Peter Bach on the Benefit of Bringing Stakeholders Together at PCOC15

The Patient-Centered Oncology Care meeting provides a great opportunity for stakeholders from across healthcare to get together, and when that happens very good things can come from it, according to Peter Bach, MD, MAPP, director of Memorial Sloan Kettering Cancer Center's Center for Health Policy and Outcomes.
Site Logo
October 14th 2015

One Winner Looks Likely in Louisiana Governor's Race: Medicaid Expansion

Mary K. Caffrey
Earlier this year, the legislature laid the groundwork for Medicaid expansion to occur in 2016.
Site Logo
October 13th 2015

How Do You Improve Geriatric Participation in Cancer Trials?

Surabhi Dangi-Garimella, PhD
The American Society of Clinical Oncology has issued a statement asking for an improved evidence base for treating older adults with cancer.
Site Logo
October 13th 2015

Example of A Clinical Care Gap: Oncologists and Genetic Counselors

Surabhi Dangi-Garimella, PhD
A new study, published in JAMA Oncology has identified a widespread gap in counseling services for patients who undergo BRCA testing.
Site Logo
October 12th 2015

Cancer Can Cause Heart Failure

Surabhi Dangi-Garimella, PhD
A study presented at the European Society of Cardiology meeting has found that cancer increases cardiac stress, which is further accentuated by chemotherapy.
Site Logo
October 12th 2015

10 Cancer Researchers Can Receive $7.5 Million in Funds

AJMC Staff
Stand Up 2 Cancer, in collaboration with the American Association for Clinical Research, will be funding innovative research grants with a potential to further translational cancer research.
Site Logo
October 12th 2015

The Need to Raise Awareness for Young Adult Cancer Care

Surabhi Dangi-Garimella, PhD
Adolescent and young adult cancer patients face multiple barriers to ensuring adequate care: from unsure providers to financial constraints. Improved care coordination and recognition of the needs of this population can lead to much improved outcomes.
Site Logo
October 12th 2015

Pediatric Oncologist A Firm Believer in the Potential of Next Generation Sequencing

Surabhi Dangi-Garimella, PhD
Evidence-Based Oncology spoke with Rajen Mody, MBBS, from the University of Michigan Health System, about his experiences treating young cancer patients, the survivorship program offered by the University of Michigan, and next generation sequencing.
Site Logo
October 12th 2015

Sticking Up for the 340B Program

Changes in the healthcare marketplace are steadily pushing changes for physicians and specialty practices of all kinds. Blaming the 340B drug discount program is both misleading and unproductive.
Site Logo
October 12th 2015

Now a New Companion Diagnostic for Nivolumab in Non-Squamous NSCLC

Surabhi Dangi-Garimella, PhD
The new test, developed by Dako, will provide information on the survival benefit of patients with non-squamous NSCLC treated with nivolumab.
Site Logo
October 10th 2015

This Week in Managed Care: October 10, 2015

Top managed care stories this week include how much waiting to see the doctor costs patients, Express Scripts announced it will cover both PCSK9 inhibitors, and HHS proposed simplifying rules for providers using electronic health record.
Site Logo
October 9th 2015

Can Cancer Survival Outcomes Help You Choose Your Site of Care?

Surabhi Dangi-Garimella, PhD
A new study published in JAMA Oncology has identified disparate survival outcomes across sites of care.
Site Logo
October 9th 2015

Nivolumab Receives Extended Approval for Advanced Lung Cancer

AJMC Staff
The PD-1 inhibitor antibody was approved by the FDA for use in patients who have progressed on platinum-based treatment.
Site Logo
October 9th 2015

NICE Believes Pembrolizumab Is Worth It in Treatment-Naïve Melanoma Patients

Surabhi Dangi-Garimella, PhD
With the final guidance expected in November, UK will follow Europe in the use of pembrolizumab in treating advanced melanoma patients refractory to previous treatment as well as those who have not been previously treated.
Dr Joseph Alvarnas Considers Survivorship and Long-Term Effects of Cancer Therapy
October 9th 2015

Dr Joseph Alvarnas Considers Survivorship and Long-Term Effects of Cancer Therapy

With new treatments helping patients with cancer to live longer, healthcare providers now have new issues of long-term survivorship to consider, said Joseph Alvarnas, MD, the editor-in-chief of Evidence-Based Oncology.
<1
...
117118119120121122123124125
...
184>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo